The Utility of the National Alzheimer's Coordinating Center's Database for the Rapid Assessment of Evolving Neuropathologic Conditions.


Journal

Alzheimer disease and associated disorders
ISSN: 1546-4156
Titre abrégé: Alzheimer Dis Assoc Disord
Pays: United States
ID NLM: 8704771

Informations de publication

Date de publication:
Historique:
pubmed: 19 4 2020
medline: 5 6 2021
entrez: 19 4 2020
Statut: ppublish

Résumé

The field of dementia research is rapidly evolving, especially with regards to our understanding of the diversity of neuropathologic changes that underlie cognitive decline. Definitions and criteria for known conditions are being periodically revised and refined, and new findings are being made about neuropathologic features associated with dementia status. The database maintained by the National Alzheimer's Coordinating Center (NACC) offer researchers a robust, rapid, and statistically well-powered method to evaluate the implications of newly identified neuropathologic conditions with regards to comorbidities, demographic associations, cognitive status, neuropsychologic tests, radiographic findings, and genetics. NACC data derive from dozens of excellent US Alzheimer disease research centers, which collectively follow thousands of research volunteers longitudinally. Many of the research participants are autopsied using state-of-the-art methods. In this article, we describe the NACC database and give examples of its use in evaluating recently revised neuropathologic diagnoses, including primary age-related tauopathy (PART), limbic predominant age-related TDP-43 encephalopathy (LATE), and the preclinical stage of Alzheimer disease neuropathologic change, based on the National Institute on Aging-Alzheimer's Association consensus guidelines. The dementia research community is encouraged to make use of this readily available database as new neuropathologic changes are recognized and defined in this rapidly evolving field.

Identifiants

pubmed: 32304374
doi: 10.1097/WAD.0000000000000380
pmc: PMC7242145
mid: NIHMS1576768
pii: 00002093-202004000-00001
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

105-111

Subventions

Organisme : NIA NIH HHS
ID : P30 AG066444
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG072946
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005133
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG047366
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG062695
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG028383
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG016976
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005681
Pays : United States

Références

Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S1-2
pubmed: 9330978
Brain. 2019 Jun 1;142(6):1503-1527
pubmed: 31039256
Acta Neuropathol. 2015 May;129(5):749-56
pubmed: 25628035
Alzheimer Dis Assoc Disord. 2017 Jul-Sep;31(3):232-238
pubmed: 27849641
Acta Neuropathol Commun. 2019 Dec 9;7(1):204
pubmed: 31818331
J Neuropathol Exp Neurol. 2020 Mar 1;79(3):305-313
pubmed: 31845964
Acta Neuropathol Commun. 2018 May 1;6(1):33
pubmed: 29716643
J Int Neuropsychol Soc. 2006 Sep;12(5):707-35
pubmed: 16961952
Curr Opin Neurobiol. 2020 Apr;61:10-22
pubmed: 31862625
J Alzheimers Dis. 2014;39(3):691-702
pubmed: 24270205
Neurology. 2016 Mar 15;86(11):1000-8
pubmed: 26888993
Acta Neuropathol. 2015 May;129(5):757-62
pubmed: 25778618
J Neuropathol Exp Neurol. 2019 Mar 1;78(3):219-228
pubmed: 30715383
Acta Neuropathol. 2016 Jan;131(1):87-102
pubmed: 26659578
Neurology. 1991 Apr;41(4):479-86
pubmed: 2011243
J Alzheimers Dis. 2011;25(4):707-17
pubmed: 21498903
Acta Neuropathol. 2016 Apr;131(4):571-85
pubmed: 26810071
Alzheimer Dis Assoc Disord. 2018 Oct-Dec;32(4):351-358
pubmed: 30376508
Neurology. 2014 Jul 29;83(5):434-40
pubmed: 24951474
Acta Neuropathol. 2016 Jan;131(1):75-86
pubmed: 26667418
Neurology. 2017 Oct 17;89(16):1707-1715
pubmed: 28916532
Psychol Aging. 2010 Mar;25(1):208-18
pubmed: 20230140
Acta Neuropathol Commun. 2018 Dec 19;6(1):142
pubmed: 30567576
Neurology. 2013 Jun 4;80(23):2121-9
pubmed: 23645594
J Neuropathol Exp Neurol. 2018 Aug 1;77(8):717-726
pubmed: 29945202
Neurodegener Dis Manag. 2012;2(2):183-195
pubmed: 22798965
J Exp Med. 2015 May 4;212(5):601-5
pubmed: 25941321
Alzheimer Dis Assoc Disord. 2018 Jan-Mar;32(1):10-17
pubmed: 29240561
Acta Neuropathol. 2007 Jul;114(1):5-22
pubmed: 17579875
Alzheimer Dis Assoc Disord. 2009 Apr-Jun;23(2):91-101
pubmed: 19474567
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):210-6
pubmed: 17132964
JAMA Neurol. 2015 May;72(5):497-8
pubmed: 25730751
PLoS Genet. 2014 Sep 04;10(9):e1004606
pubmed: 25188341
Lab Invest. 2019 Jul;99(7):1049-1055
pubmed: 30710118
Arch Neurol. 2009 Dec;66(12):1476-81
pubmed: 20008651
Acta Neuropathol. 2014 Dec;128(6):755-66
pubmed: 25348064
Neuropsychology. 2010 Jan;24(1):49-67
pubmed: 20063946
Alzheimers Dement. 2012 Jan;8(1):1-13
pubmed: 22265587
Science. 2006 Oct 6;314(5796):130-3
pubmed: 17023659
Alzheimers Dement. 2011 May;7(3):280-92
pubmed: 21514248

Auteurs

Charles Mock (C)

National Alzheimer's Coordinating Center, University of Washington, Seattle, WA.

Merilee Teylan (M)

National Alzheimer's Coordinating Center, University of Washington, Seattle, WA.

Gary Beecham (G)

Miller School of Medicine, John P. Hussman Institute for Human Genomics, University of Miami, Miami.

Lilah Besser (L)

School of Urban and Regional Planning, Florida Atlantic University, Boca Raton, FL.

Nigel J Cairns (NJ)

College of Medicine and Health, University of Exeter, Exeter, UK.

John F Crary (JF)

Neuropathology Brain Bank & Research Core, Departments of Pathology & Neuroscience, Ronald M. Loeb Center for Alzheimer's Disease, Icahn School of Medicine at Mount Sinai, Friedman Brain Institute, New York, NY.

Yuriko Katsumata (Y)

Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY.

Peter T Nelson (PT)

Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY.

Walter Kukull (W)

National Alzheimer's Coordinating Center, University of Washington, Seattle, WA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH